In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis ...

Biologic therapies are safe for use in patients with psoriasis who also have active or recent cancer when compared with conventional therapies.

Medicare coverage for biologic therapies -- a mainstay of treatment for rheumatoid arthritis-- has been in flux recently. Medicare Part B coverage for biologic therapy ended in 2004, and the Medicare ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

Overall, the “Hidradenitis Suppuritiva Update 2026” session underscored a new treatment paradigm: HS care in 2026 requires early diagnosis, systemic screening, combination medical therapy, and ...

Earlier initiation of biologics in severe asthma could prevent thousands of deaths and save billions in healthcare costs by reducing exacerbations and healthcare resource utilization. Real-world data ...

I started taking a second biologic to treat my eczema and asthma at the end of last year. My allergist and dermatologist had recommended I begin Dupixent (dupilumab) injections about five years ago, ...

Please provide your email address to receive an email when new articles are posted on . Less than 15% of PCPs reported managing patients with uncontrolled asthma at least once a week. More PCPs ...

Adults with severe asthma who had poor inhaled corticosteroid/long-acting beta agonist adherence in their first year of tezepelumab did not differ from those with better adherence in several clinical ...

A high quantity of opioid medication among individuals hospitalized with acute severe ulcerative colitis is linked to a delay in administration of biologic rescue therapy. High opioid use during acute ...